Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.660
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
0.652
-0.008 (-1.21%)
Pre-market: Apr 29, 2026, 7:17 AM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $71.16 million as of April 29, 2026. Its market cap has increased by 1,054.56% in one year.
Market Cap
71.16M
Enterprise Value
71.16M
1-Year Change
1,054.56%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $71.16M, an increase of 106.31%. That is a compound annual growth rate of 56.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 71.16M | 34.69% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 75.73M |
| TScan Therapeutics | 75.73M |
| Filana Therapeutics | 75.36M |
| Pliant Therapeutics | 74.92M |
| Acrivon Therapeutics | 73.61M |
| Fortress Biotech | 72.13M |
| Actuate Therapeutics | 68.76M |
| OS Therapies | 68.52M |